Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

peptide receptor radionuclide therapy

(PEP-tide reh-SEP-ter RAY-dee-oh-NOO-klide THAYR-uh-pee)
A type of radiation therapy used to treat certain types of neuroendocrine tumors. A radioactive chemical is linked to a peptide (small protein) that targets cancer cells. When this radioactive peptide is injected into the body, it binds to a specific receptor found on some cancer cells. The radioactive peptide builds up in these cells and helps kill the cancer cells without harming normal cells. Peptide receptor radionuclide therapy is a type of targeted therapy. Also called PRRT.
Search NCI's Dictionary of Cancer Terms